Contraindicated (1)pentobarbital will minimize the level or influence of naloxegol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Utilization of naloxegol with potent CYP3A4 inducers is just not proposed Prevent; coadministration with CYP3A inducers may possibly end in lowered plasma concentrations of elvitegravir and/or a concomitantly administered proteas... https://billl999oet8.wikinstructions.com/user